HOME > News > Press Releases > 2024.12.17 Glac Biotech × Public Good — Supporting Whole-Person Education and Building Dreams for the Next Generation
2024.12.17 Glac Biotech × Public Good — Supporting Whole-Person Education and Building Dreams for the Next Generation
At Glac Biotech, we’ve always believed that health is more than just the absence of illness — it’s a vital energy that empowers the next generation to dream bigger and go further. That’s why, beyond advancing the science of probiotics, we devote our hearts and resources to public welfare initiatives that nurture both body and spirit.
A Team of Young Dreamers in Tainan
At Anshun Elementary School in Tainan, a spirited group of children pick up their badminton rackets after class each day. Though small in stature, their determination is larger than life. They sweat, they stumble, they encourage one another, and they rise together — embodying teamwork and resilience far beyond their years.
Watching their dedication moved us deeply. We wanted to do more than cheer from the sidelines. To help these young athletes focus fully on their dreams, Glac Biotech stepped forward with tangible support: providing brand-new uniforms and competition funding. This way, the Anshun Badminton Team could train and compete in a nurturing environment that fuels both their growth and confidence.
This year, we were thrilled to witness their hard work pay off as the team delivered outstanding performances at the 2024 National Elementary School Badminton Championship. Their victories lit up the court — and our hearts.
Building the Future with Care and Expertise
For us, “Professionalism × Warmth” isn’t just a slogan; it’s a promise. By combining our expertise in probiotic innovation with a commitment to holistic education and community care, we’re investing in the health and dreams of Taiwan’s next generation.
At Glac Biotech, every breakthrough in science is matched with a step toward a healthier, more hopeful future for society. And just like the young athletes of Anshun, we’re determined to keep moving forward — stronger, together.
A Team of Young Dreamers in Tainan
At Anshun Elementary School in Tainan, a spirited group of children pick up their badminton rackets after class each day. Though small in stature, their determination is larger than life. They sweat, they stumble, they encourage one another, and they rise together — embodying teamwork and resilience far beyond their years.
Watching their dedication moved us deeply. We wanted to do more than cheer from the sidelines. To help these young athletes focus fully on their dreams, Glac Biotech stepped forward with tangible support: providing brand-new uniforms and competition funding. This way, the Anshun Badminton Team could train and compete in a nurturing environment that fuels both their growth and confidence.
This year, we were thrilled to witness their hard work pay off as the team delivered outstanding performances at the 2024 National Elementary School Badminton Championship. Their victories lit up the court — and our hearts.
Building the Future with Care and Expertise
For us, “Professionalism × Warmth” isn’t just a slogan; it’s a promise. By combining our expertise in probiotic innovation with a commitment to holistic education and community care, we’re investing in the health and dreams of Taiwan’s next generation.
At Glac Biotech, every breakthrough in science is matched with a step toward a healthier, more hopeful future for society. And just like the young athletes of Anshun, we’re determined to keep moving forward — stronger, together.
Media Coverage (Extended Reading)
Commercial Times (CTEE), Taiwan — Dec 17, 2024 (Chinese)
https://www.ctee.com.tw/news/20241217701561-431205
-
2024.4.2 Glac Biotech’s Probiotic Strains F-1 & CP-9 — The Secret Engine Powering Global OEM Success
-
2025.7.9 Glac Biotech Donates Probiotics to Support Vulnerable Communities in Changhua
-
2024.7.23 Glac Biotech Unveils Next-Generation Probiotic Technology and Brain Health Innovations
-
2025.08.07 Taiwan’s First GRAS-Certified Probiotic — Glac Biotech’s MP108 Achieves Historic U.S. FDA Recognition